Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy PetMed Express stock

Own PetMed Express stock in just a few minutes.

PetMed Express, Inc is a pharmaceutical retailers business based in the US. PetMed Express shares (PETS) are listed on the NASDAQ and all prices are listed in US Dollars. PetMed Express employs 214 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in PetMed Express

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – PETS – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

PetMed Express share price

Use our graph to track the performance of PETS stocks over time.

PetMed Express shares at a glance

Information last updated 2021-04-23.
52-week range$27.22 - $56.58
50-day moving average $33.44
200-day moving average $32.77
Wall St. target price$33.00
PE ratio 20.5065
Dividend yield $1.11 (3.53%)
Earnings per share (TTM) $1.53

Buy PetMed Express shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
A free way to invest in stocks, ETFs and crypto.
Robinhood
$0
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, ETFs, Currencies
$0 + $0.65/contract, $1 minimum
0%
N/A
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
$0
Stocks, ETFs
N/A
$0 per month
N/A
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy PetMed Express stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is PetMed Express under- or over-valued?

Valuing PetMed Express stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of PetMed Express's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

PetMed Express's P/E ratio

PetMed Express's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 21x. In other words, PetMed Express shares trade at around 21x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

PetMed Express's PEG ratio

PetMed Express's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.58. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into PetMed Express's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

PetMed Express's EBITDA

PetMed Express's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $40.1 million.

The EBITDA is a measure of a PetMed Express's overall financial performance and is widely used to measure a its profitability.

PetMed Express financials

Revenue TTM $311.8 million
Operating margin TTM 12.09%
Gross profit TTM $81.2 million
Return on assets TTM 14.88%
Return on equity TTM 23.08%
Profit margin 9.88%
Book value $6.92
Market capitalisation $639 million

TTM: trailing 12 months

Shorting PetMed Express shares

There are currently 4.3 million PetMed Express shares held short by investors – that's known as PetMed Express's "short interest". This figure is 6.7% up from 4.1 million last month.

There are a few different ways that this level of interest in shorting PetMed Express shares can be evaluated.

PetMed Express's "short interest ratio" (SIR)

PetMed Express's "short interest ratio" (SIR) is the quantity of PetMed Express shares currently shorted divided by the average quantity of PetMed Express shares traded daily (recently around 473269.58424508). PetMed Express's SIR currently stands at 9.14. In other words for every 100,000 PetMed Express shares traded daily on the market, roughly 9140 shares are currently held short.

However PetMed Express's short interest can also be evaluated against the total number of PetMed Express shares, or, against the total number of tradable PetMed Express shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case PetMed Express's short interest could be expressed as 0.21% of the outstanding shares (for every 100,000 PetMed Express shares in existence, roughly 210 shares are currently held short) or 0.265% of the tradable shares (for every 100,000 tradable PetMed Express shares, roughly 265 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against PetMed Express.

Find out more about how you can short PetMed Express stock.

PetMed Express share dividends

73%

Dividend payout ratio: 72.73% of net profits

Recently PetMed Express has paid out, on average, around 72.73% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 3.56% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), PetMed Express shareholders could enjoy a 3.56% return on their shares, in the form of dividend payments. In PetMed Express's case, that would currently equate to about $1.11 per share.

PetMed Express's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.

PetMed Express's most recent dividend payout was on 11 February 2021. The latest dividend was paid out to all shareholders who bought their shares by 28 January 2021 (the "ex-dividend date").

Have PetMed Express's shares ever split?

PetMed Express's shares were split on a 3:1 basis on 3 March 1999. So if you had owned 1 share the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your PetMed Express shares – just the quantity. However, indirectly, the new 66.7% lower share price could have impacted the market appetite for PetMed Express shares which in turn could have impacted PetMed Express's share price.

PetMed Express share price volatility

Over the last 12 months, PetMed Express's shares have ranged in value from as little as $27.2167 up to $56.5815. A popular way to gauge a stock's volatility is its "beta".

PETS.US volatility(beta: 0.65)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while PetMed Express's is 0.6492. This would suggest that PetMed Express's shares are less volatile than average (for this exchange).

PetMed Express overview

PetMed Express, Inc. , together with its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, and other health products for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventative, flea and tick preventative, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, strollers, and other pet supplies. It sells its products through its Internet website; telephone contact center; and direct mail/print through brochures and postcards. PetMed Express, Inc.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site